Summary

The Multivalent Vaccines market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

market size and forecast

Regional market size, production data and export & import

Key manufacturers profile, products & services, sales data of business

market size by Major Application

market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:

GlaxoSmithKline, plc (U.K.)

Pfizer, Inc. (U.S.)

Merck & Co., Inc. (U.S.)

Sanofi Pasteur SA (France)

Astellas Pharma Inc. (Japan)

CSL Limited (Australia)

Emergent BioSolutions, Inc. (U.S.)

Johnson & Johnson (U.S.)

MedImmune, LLC (U.S.)

Serum Institute of India Pvt. Ltd. (India)

Bavarian Nordic (Denmark)

Mitsubishi Tanabe Pharma Corporation (Japan)

Daiichi Sankyo (Japan)

Protein Sciences Corporation (U.S.)

Panacea Biotec (India)

Major applications as follows:

Pediatrics

Adults

Major Type as follows:

Conjugate Vaccines

Inactivated and Subunit Vaccines

Live Attenuated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 GlaxoSmithKline, plc (U.K.)
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Pfizer, Inc. (U.S.)
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Merck & Co., Inc. (U.S.)
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Sanofi Pasteur SA (France)
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Astellas Pharma Inc. (Japan)
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 CSL Limited (Australia)
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Emergent BioSolutions, Inc. (U.S.)
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Johnson & Johnson (U.S.)
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 MedImmune, LLC (U.S.)
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Serum Institute of India Pvt. Ltd. (India)
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Bavarian Nordic (Denmark)
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Mitsubishi Tanabe Pharma Corporation (Japan)
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 Daiichi Sankyo (Japan)
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Protein Sciences Corporation (U.S.)
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15 Panacea Biotec (India)
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Pediatrics
4.1.1 Overview
4.1.2 Pediatrics Market Size and Forecast
4.2 Adults
4.2.1 Overview
4.2.2 Adults Market Size and Forecast
5 Market by Type
5.By Conjugate Vaccines
5.1 Conjugate Vaccines
5.1.1 Overview
5.1.2 Conjugate Vaccines Market Size and Forecast
5.2 Inactivated and Subunit Vaccines
5.2.1 Overview
5.2.2 Inactivated and Subunit Vaccines Market Size and Forecast
5.3 Live Attenuated Vaccines
5.3.1 Overview
5.3.2 Live Attenuated Vaccines Market Size and Forecast
5.4 Toxoid Vaccines
5.4.1 Overview
5.4.2 Toxoid Vaccines Market Size and Forecast
5.5 Recombinant Vaccines
5.5.1 Overview
5.5.2 Recombinant Vaccines Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion